β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-blockers are associated with reduced mortality. The goal of this study was to determine the association between β-blocker use and mortality in patients with AMI without HF or left ventricular systolic dysfunction (L...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American College of Cardiology Ročník 69; číslo 22; s. 2710
Hlavní autoři:	Dondo, Tatendashe B, Hall, Marlous, West, Robert M, Jernberg, Tomas, Lindahl, Bertil, Bueno, Hector, Danchin, Nicolas, Deanfield, John E, Hemingway, Harry, Fox, Keith A A, Timmis, Adam D, Gale, Chris P
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 06.06.2017
Témata:	Adrenergic beta-Antagonists - administration & dosage Aged Dose-Response Relationship, Drug Electrocardiography Female Follow-Up Studies Heart Failure - complications Heart Failure - drug therapy Hospital Mortality - trends Humans Male Middle Aged Myocardial Infarction - complications Myocardial Infarction - drug therapy Myocardial Infarction - mortality Propensity Score Prospective Studies Registries Survival Rate - trends United Kingdom - epidemiology Ventricular Dysfunction - complications Ventricular Dysfunction - drug therapy NSTEMI preserved left ventricular systolic function STEMI average treatment effect survival propensity score
ISSN:	1558-3597, 1558-3597
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!